Acute leukemia association with psoriasis: a report on 100 patients from a single center in China.
Wang
Ying
Y
Mi
Yingchang
Y
Li
Dapeng
D
Xue
Yanping
Y
Bian
Shougeng
S
Wang
Jianxiang
J
D000328:Adult; D000368:Aged; D002681:China; D015331:Cohort Studies; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009687:Nuclear Proteins / Q000235:genetics; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications; D000071156:Promyelocytic Leukemia Protein; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy* / Q000235:genetics; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D011929:Razoxane / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018168:Receptors, Retinoic Acid / Q000235:genetics; D000072482:Retinoic Acid Receptor alpha; D014157:Transcription Factors / Q000235:genetics; D025521:Tumor Suppressor Proteins / Q000235:genetics; D055815:Young Adult
D009687:Nuclear Proteins; D000071156:Promyelocytic Leukemia Protein; C000607071:RARA protein, human; D011838:Radiation-Sensitizing Agents; D018168:Receptors, Retinoic Acid; D000072482:Retinoic Acid Receptor alpha; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins; C070576:PML protein, human; C031186:bimolane; D011929:Razoxane